Logo image
Identification of a small molecule HIV-1 inhibitor that targets the capsid hexamer
Journal article   Open access   Peer reviewed

Identification of a small molecule HIV-1 inhibitor that targets the capsid hexamer

Jimmy P. Xu, Jeffrey D. Branson, Rae Lawrence and Simon Cocklin
Bioorganic & medicinal chemistry letters, v 26(3), pp 824-828
01 Feb 2016
PMID: 26747394
url
https://europepmc.org/articles/pmc4728034View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Chemistry Chemistry, Medicinal Chemistry, Organic Life Sciences & Biomedicine Pharmacology & Pharmacy Physical Sciences Science & Technology
The HIV-1 CA protein is an attractive therapeutic target for the development of new antivirals. An inter-protomer pocket within the hexamer configuration of the CA, which is a binding site for key host dependency factors, is an especially appealing region for small molecule targeting. Using a field-based pharmacophore derived from an inhibitor known to interact with this region, coupled to biochemical and biological assessment, we have identified a new compound that inhibits HIV-1 infection and that targets the assembled CA hexamer. (C) 2015 Elsevier Ltd. All rights reserved.

Metrics

1 Record Views
18 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
International collaboration
Web of Science research areas
Chemistry, Medicinal
Chemistry, Organic
Logo image